Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention1: NIL: Nil
Control Intervention1: NIL: Nil
Sponsors
Dr Yash Goel
Eligibility
Inclusion criteria
Inclusion criteria: Patients (aged 18 years or older) of any gender or ethnicity. Patients requiring statin therapy. Patients who are willing and able to provide informed consent.
Exclusion criteria
Exclusion criteria: Patients with severe liver or kidney dysfunction Patients with uncontrolled malignancy or other life-threatening conditions. Pregnant or breastfeeding women. Patients with uncontrolled endocrine disorders Patients with cognitive impairment or psychiatric disorders that may interfere with their ability to provide informed consent or comply with the study protocol. patients who are unwilling to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Study the safety profile of statin therapy at a tertiary care centre Timepoint: To Study the safety profile of statin therapy at a tertiary care centre at every 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the adverse effects associated with the use of statins. Timepoint: To evaluate the adverse effects associated with the use of statins at every 4 weeks | — |
Countries
India
Contacts
Public ContactDr Yash Goel
Teerthanker Mahaveer University Medical College and Research Centre
Outcome results
None listed